GlobalSkin hosted a Patient Leader Dialogue Workshop on atopic eczema on September 13, 2018 in Paris, France. Moderated by Christine Janus, GlobalSkin’s CEO, the workshop was attended by patient advocates and leaders of patient organizations from eight countries who work to support patients suffering from eczema and atopic dermatitis around the world. The goal of the workshop was to look at challenges and recommend policy drivers that could positively influence the prioritization of atopic eczema among healthcare decision-makers. The recommended drivers are:
1. Empowering patients and patient organizations
2. Quantifying impact of disease
3. Developing position papers on key topics.
LEO Pharma provided an educational grant to cover the costs associated with this highly informative session.
Read the complete publication: Policy Drivers in Atopic Eczema: Patient Leader Dialogue Report, November 2018.